 |
      |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|||||||
|
ALPHAGAN® P is an eye medication that's proven to lower elevated intraocular pressure (IOP). Lowering IOP is the only treatable risk factor to prevent glaucomatous vision loss. If you have been prescribed ALPHAGAN® P, your eye care professional has determined that you have glaucoma (open-angle glaucoma) or ocular hypertension (elevated IOP). Your eye care professional chose ALPHAGAN® P ophthalmic solution for you because it is proven effective for lowering IOP. In addition, it has been specially formulated to reduce drug exposure.
|
 |
|
ALPHAGAN® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Important Safety Information ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision. Please click here for full Prescribing Information. |
|
©2008 Allergan, Inc., Irvine, CA 92612 | ® marks owned by Allergan, Inc. |